2025 and Beyond

As we end our 120th year, we are taking stock of the progress we’ve made while looking ahead to the opportunities and challenges in 2025 and beyond.

You helped achieve important victories for lung health: dramatic reductions in youth vaping, significantly improved lung cancer survival rates and increased funding for lung cancer research. None of it would have been possible without your support and advocacy. So, thank you from the bottom of our hearts . . . and lungs!

We are in the middle of our year-end fundraising campaign, and if you can afford a one?time or monthly gift, we would be most grateful. You can double your donation to help us meet the challenges of 2025 and beyond. Every dollar you give will be matched, dollar?for?dollar, up to $108,900.

Vehicle donation: There’s still time to make a tax?deductible vehicle donation before the end of the year. Here’s our Vehicle Donation FAQ and Online Vehicle Donation Form

Quitting Is Hard: Let Us Help

This stat makes it clear how difficult it is to quit tobacco:

• Less than 1 in 10 adults who smoke cigarettes succeed in quitting each year.

However, 57% of people who smoke and use other tobacco products succeed in staying tobacco?free with our Freedom From Smoking® program, which is one of the most effective cessation programs in the country.

For teens and young adults, we have specialized quit programs, including peer?led state programs.

If you are helping a loved one or friend, we strongly recommend that you read Help Someone Quit Smoking, which includes helpful tips and resources.

You or a loved one can always call our Tobacco Quitline to speak to someone directly for support.

To learn more about what quit options might be right for you or a loved one, email the team at [email protected].

Top Lung News

- Simple Breathing Exercises to Help You Manage Stress

- Antibiotics vs. Antivirals: What You Need to Know

- December Mission Moment

More Lung News

Skip the Elevator and Take the Stairs

On January 8—National Take the Stairs Day—we’re asking you, your family and friends to take the stairs for lung health.

Taking the stairs is a step toward a healthier lifestyle. The health benefits of stair climbing include improved balance and coordination, as well as the strengthening of more major muscle groups.

You can turn your stair climbing into a healthy habit by signing up for one of our Fight For Air Climb events at iconic venues across the country.

All are welcome, from beginners to elite climbers, firefighters and first responders. Step up for lung health and find your Climb.

What to Know About Pneumonia

• Pneumonia is a lung infection commonly caused by bacteria and viruses.
• Mycoplasma pneumoniae (also known as walking pneumonia) and pneumococcal pneumonia, are two common causes of bacterial pneumonia.
• Flu, COVID?19 and RSV are common causes of viral pneumonia.

Since antibiotics should only be used for bacterial infections, it’s important for you to speak to your healthcare provider about immunizations to help prevent pneumonia and treatment options, if infected.

The Lung Association has created resources to help you learn more about pneumonia:

• Nine Things to Know About Pneumonia (blog)
• Treating Community-Acquired Bacterial Pneumonia (webpage)

Developed by the American Lung Association with a grant from Paratek Pharmaceuticals, Inc.

Pneumococcal Vaccination Education for Healthcare Professionals

Each year pneumococcal pneumonia causes around 150,000 hospitalizations and has a 5%?7% mortality rate.

Pneumococcal vaccination is recommended for adults 50 years or older and adults 19?49 with certain underlying health conditions and risk factors, such as chronic lung disease, chronic heart disease, diabetes and cigarette smoking.

We’re encouraging healthcare professionals to assess patient vaccination status at every opportunity and make a strong recommendation for vaccination when appropriate.

• Go to Lung.org/HCP-pneumococcal for all the provider resources, including:
• Motivational Interviewing Scenarios
• FAQ Video featuring Dr. Meredith McCormack
• Four Providers Discuss Best Practices

This content was developed in partnership with Pfizer.

Treating Moderate to Severe COPD

Starting on January 12, Dr. Jesse Miller will answer questions about treating moderate to severe COPD and endobronchial valve treatment (EBV) during a week?long Ask the Expert event on the Living with COPD Inspire Online Community. EBV is a minimally invasive treatment option for some people living with advanced emphysema. Join the Living with COPD Inspire Online Community so you can participate in this important event.